Latest news
A universal toolkit for editing bacterial DNA
A major collaboration involving nine labs has transferred a particularly useful DNA editing system from E. coli into 14 new species of bacteria, spanning three major branches of the bacterial family tree.
Crab shell by-products could help regulate the marine lifetime of biodegradable plastics
Researchers show that crab shell by-products can reduce the breakdown rate of biodegradable plastics in seawater by altering the microbial communities that colonize their surfaces, known as the plastisphere.
How AI can help us count the ‘good’ viruses used in biopharmaceuticals
Researchers have developed a new methodology that uses artificial intelligence (AI) tools to identify and count target viruses more efficiently than previous techniques. The new approach can be used in applications such as pharmaceutical biomanufacturing.
From precision intervention to a “virtual gut”: how close are we to predicting and steering the human microbiome?
A new review maps how multi-omics and machine learning could turn host-microbiome research from correlation hunting into actionable prediction and personalized therapy.
Automation platform enables high-resolution spatial mapping of microbial communities
Researchers have developed a sequential error-robust FISH spatial mapping platform (SEER-Map) which enables fully automated, high-multiplexity spatial profiling of complex microbial communities at single-cell resolution.
Researchers deploy phage therapy in new frontier against antimicrobial resistant infectious diseases
A revelatory treatment for patients with life-threatening infectious diseases is being pioneered in Melbourne. VICPhage, a clinical partnership between The Alfred and Monash, is one of the first in Australia to offer end-to-end capacity in phage therapy to treat some of the most challenging infections.
Crab shell by-products could help regulate the marine lifetime of biodegradable plastics
Researchers show that crab shell by-products can reduce the breakdown rate of biodegradable plastics in seawater by altering the microbial communities that colonize their surfaces, known as the plastisphere.
How AI can help us count the ‘good’ viruses used in biopharmaceuticals
Researchers have developed a new methodology that uses artificial intelligence (AI) tools to identify and count target viruses more efficiently than previous techniques. The new approach can be used in applications such as pharmaceutical biomanufacturing.
From precision intervention to a “virtual gut”: how close are we to predicting and steering the human microbiome?
A new review maps how multi-omics and machine learning could turn host-microbiome research from correlation hunting into actionable prediction and personalized therapy.
CDI breakthroughs lead to new drug development deal for deadly NTM bacteria
Scientists have developed new compounds against non-tuberculous mycobacteria which are now the subject of a new collaboration and license agreement with the Switzerland-based and publicly listed BioVersys AG.
Vanderbilt Center for Antibody Therapeutics signs agreement to develop anti-measles antibody treatment
The Vanderbilt Center for Antibody Therapeutics has signed an option agreement with Saravir Biopharma Inc. for the company to develop human monoclonal antibodies isolated in the laboratory of James Crowe Jr., MD, for the treatment and prevention of measles.
Cleanroom specialist Total Clean Air appointed European partner for US-based biodecontamination firm, TOMI
UK-BASED cleanroom engineering company Total Clean Air (TCA), a UKAS ISO 17025-accredited cleanroom constructor, has been appointed European partner for US-based decontamination technology firm TOMI®Environmental Solutions.
A universal toolkit for editing bacterial DNA
A major collaboration involving nine labs has transferred a particularly useful DNA editing system from E. coli into 14 new species of bacteria, spanning three major branches of the bacterial family tree.
Computational approach takes the guesswork out of drug development for Chagas disease
Researchers have established a computational protocol that could accelerate the development of more effective treatments for life-threatening parasitic infections such as Chagas disease, by enabling scientists to accurately identify reactions that can result in successful drug candidates without the need for trial and error.
Researchers fight oral cancer with bioengineered chewing gum
Research shows that antiviral and antibacterial chewing gums reduce the levels of three microbes linked to worse outcomes in oral cancers, paving the way for more effective and affordable therapies.
How scientists are breeding spinach to better withstand Pythium
Breeding efforts to improve spinach tolerance to a pathogen called Pythium will help both indoor and outdoor growers of the popular leafy green.
WHO certifies the Bahamas for eliminating mother-to-child transmission of HIV
In a landmark achievement for Caribbean public health, the World Health Organization (WHO) congratulates The Bahamas for becoming the latest Caribbean nation to be certified as having eliminated the mother-to-child transmission of HIV.
Flu vaccine no longer required for U.S. military
The U.S. military is ending its long-standing requirement that service members receive the annual flu shot, a decision announced by Defense Secretary Pete Hegseth.